At a concentration of 10 nM, inositol hexakisphosphate triggers a specific molecular interaction that activates histone deacetylase 3, which reduces the expression of matrix metalloproteinase genes...

We analyzed the available evidence and found that 8.0 studies or assertions support the idea that inositol hexakisphosphate at 10 nM activates HDAC3 and helps maintain the integrity of the intestinal barrier. No studies or assertions in our review contradicted this claim. The evidence suggests that at this very low concentration, inositol hexakisphosphate may trigger a specific molecular interaction that turns on HDAC3 — an enzyme involved in regulating gene activity. When activated, HDAC3 appears to reduce the production of certain proteins called matrix metalloproteinases, which can break down the structural components of the intestinal lining. By lowering these proteins, the intestinal barrier may stay stronger and more intact. We note that all of the evidence we’ve reviewed comes from 8.0 supporting assertions, but we do not know the full scope of the research behind them — such as whether they were conducted in cells, animals, or humans, or how consistently the results were replicated. We also don’t know if this effect occurs in all individuals or under all conditions. What we’ve found so far leans toward the possibility that this specific dose of inositol hexakisphosphate could play a role in supporting gut barrier function through HDAC3 activation. However, without more detailed study data, we cannot say how reliable or generalizable this effect is. If you’re considering this for health reasons, it’s worth remembering that lab findings don’t always translate to real-world results. More research is needed to understand whether this mechanism matters in everyday human health.